Lam Research Corporation $LRCX Shares Bought by Mediolanum International Funds Ltd

Mediolanum International Funds Ltd lifted its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 10.1% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 172,688 shares of the semiconductor company’s stock after buying an additional 15,884 shares during the period. Mediolanum International Funds Ltd’s holdings in Lam Research were worth $16,785,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of LRCX. Vanguard Group Inc. increased its stake in Lam Research by 1.1% in the second quarter. Vanguard Group Inc. now owns 130,609,265 shares of the semiconductor company’s stock valued at $12,713,506,000 after purchasing an additional 1,457,163 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Lam Research by 14.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock valued at $3,954,188,000 after buying an additional 5,102,589 shares during the period. Geode Capital Management LLC increased its stake in shares of Lam Research by 3.5% during the 2nd quarter. Geode Capital Management LLC now owns 33,802,736 shares of the semiconductor company’s stock valued at $3,280,484,000 after acquiring an additional 1,135,405 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Lam Research by 2.8% during the 1st quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company’s stock worth $1,259,947,000 after acquiring an additional 472,636 shares during the period. Finally, Legal & General Group Plc lifted its holdings in shares of Lam Research by 3.3% during the 2nd quarter. Legal & General Group Plc now owns 10,879,674 shares of the semiconductor company’s stock worth $1,059,027,000 after acquiring an additional 343,766 shares during the period. Institutional investors and hedge funds own 84.61% of the company’s stock.

Insider Activity at Lam Research

In related news, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares in the company, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the sale, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. The trade was a 3.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 102,608 shares of company stock valued at $14,916,496 in the last 90 days. 0.31% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages recently commented on LRCX. HSBC set a $127.00 price target on shares of Lam Research and gave the stock a “hold” rating in a research report on Tuesday, September 30th. Weiss Ratings restated a “buy (b)” rating on shares of Lam Research in a report on Monday. Deutsche Bank Aktiengesellschaft lifted their target price on Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. UBS Group set a $165.00 price target on Lam Research and gave the company a “buy” rating in a research report on Thursday, October 23rd. Finally, Argus raised their price objective on Lam Research from $105.00 to $120.00 and gave the stock a “buy” rating in a report on Friday, August 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $149.04.

Lam Research Trading Up 2.2%

Shares of LRCX opened at $142.65 on Friday. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $167.15. The stock’s 50-day moving average is $144.17 and its two-hundred day moving average is $111.89. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. The stock has a market cap of $179.17 billion, a PE ratio of 31.42, a P/E/G ratio of 1.68 and a beta of 1.87.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company’s revenue was up 27.7% on a year-over-year basis. During the same period last year, the business posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio is 22.91%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.